| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Oct 06, 2022 |
|||||||||
|
Conagra Brands
CAG
|
Q1 FY23 | $0.57 | $0.52 | $2.90B | $2.85B |
NYSE |
|||
|
Constellation Brands
STZ
|
Q2 FY23 | $3.17 | $2.88 | $2.66B | $2.51B |
NYSE |
|||
| Q3 FY22 | $0.69 | $0.76 | $1.60B | $1.60B |
NYSE |
||||
|
Levi Strauss
LEVI
|
Q3 FY22 | $0.40 | $0.37 | $1.52B | $1.58B |
NYSE |
|||
|
IDT
IDT
|
Q4 FY22 | $0.70 | - | $328.56M | - |
NYSE |
|||
|
AngioDynamics
ANGO
|
Q1 FY23 | -$0.06 | -$0.02 | $81.54M | $83.43M |
NASDAQ |
|||
|
Accolade
ACCD
|
Q2 FY23 | -$0.66 | -$0.71 | $87.64M | $82.86M |
NASDAQ |
|||
|
Lifecore Biomedical
LFCR
|
Q1 FY23 | -$0.32 | -$0.13 | $43.36M | $42.74M |
NASDAQ |
|||
|
Educational Development
EDUC
|
Q2 FY23 | -$0.10 | -$0.02 | $19.42M | $26.40M |
NASDAQ |
|||
|
Park Aerospace
PKE
|
Q2 FY23 | $0.09 | - | $13.88M | - |
NYSE |
|||
|
Nurix Therapeutics
NRIX
|
- | -$0.90 | -$0.99 | $10.79M | $12.07M |
NASDAQ |
|||
|
Aehr Test Systems
AEHR
|
- | $0.05 | $0.01 | $10.67M | $8.52M |
NASDAQ |
|||
| Show 2 more companies | |||||||||
